A Global Enhanced Pharmacovigilance Pregnancy Surveillance Study of Pregnant Women Exposed to Yervoy® with 5-year Pediatric Follow-up (CA184-487)

19/05/2017
23/03/2021
EU PAS number:
EUPAS18596
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information